BioCryst Pharmaceuticals, Inc. (BCRX) vs UroGen Pharma Ltd. (URGN)
A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and UroGen Pharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCRX
BioCryst Pharmaceuticals, Inc.
$8.04HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
URGN
UroGen Pharma Ltd.
$41.86HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — BCRX vs URGN
growth of $100 · dividends reinvested · last 9yBCRX +24.8% (+2.5%/yr)URGN +206.0% (+13.2%/yr)URGN compounded faster over this window
BCRX URGN
BCRX vs URGN: by the numbers
- •BCRX is the larger company ($2.04B vs $2.04B market cap).
- •Both run net losses; BCRX's is the smaller (-40.90% vs -51.73% net margin).
- •BCRX grew revenue faster over the past five years (64.07% vs 42.66% CAGR).
Metrics side by side
Valuation
| Metric | BCRX | URGN |
|---|---|---|
| P/S ratio | 2.17 | 10.81 |
| FCF yield | 17.49% | N/A |
Profitability
| Metric | BCRX | URGN |
|---|---|---|
| Gross margin | 97.82% | 90.85% |
| Operating margin | 38.98% | -113.73% |
| Net margin | -40.90% | -51.73% |
| ROIC | -89.73% | -34.96% |
Growth (annualized)
| Metric | BCRX | URGN |
|---|---|---|
| Revenue CAGR (5Y) | 64.07% | 42.66% |
| Total return CAGR (5Y) | -10.02% | 20.32% |
Frequently asked
- Which has grown faster, BCRX or URGN?
- Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus URGN at 42.66%.
- How have BCRX and URGN total returns compared?
- Over the past 5 years, BCRX delivered -10.02% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioCryst Pharmaceuticals ROEUroGen Pharma ROEBioCryst Pharmaceuticals operating marginUroGen Pharma operating marginBioCryst Pharmaceuticals revenue growthUroGen Pharma revenue growthBioCryst Pharmaceuticals free cash flowUroGen Pharma free cash flow
BioCryst Pharmaceuticals & UroGen Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.